vs

Side-by-side financial comparison of HomeTrust Bancshares, Inc. (HTB) and Immunocore Holdings plc (IMCR). Click either name above to swap in a different company.

Immunocore Holdings plc is the larger business by last-quarter revenue ($104.5M vs $53.6M, roughly 1.9× HomeTrust Bancshares, Inc.). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs 3.7%). HomeTrust Bancshares, Inc. produced more free cash flow last quarter ($45.3M vs $-35.5M). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs 3.5%).

HomeTrust Bancshares Inc. is an Asheville, North Carolina–based bank holding company with $4.3 billion in assets and 33 branches in North and South Carolina, Georgia and Tennessee. It is the parent of seven community banks—HomeTrust Bank, Tryon Federal Bank, Shelby Savings Bank, Home Savings Bank, Industrial Federal Bank, Cherryville Federal Bank and Rutherford County Bank.

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

HTB vs IMCR — Head-to-Head

Bigger by revenue
IMCR
IMCR
1.9× larger
IMCR
$104.5M
$53.6M
HTB
Growing faster (revenue YoY)
IMCR
IMCR
+20.6% gap
IMCR
24.3%
3.7%
HTB
More free cash flow
HTB
HTB
$80.9M more FCF
HTB
$45.3M
$-35.5M
IMCR
Faster 2-yr revenue CAGR
IMCR
IMCR
Annualised
IMCR
21.7%
3.5%
HTB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HTB
HTB
IMCR
IMCR
Revenue
$53.6M
$104.5M
Net Profit
Gross Margin
97.4%
Operating Margin
37.0%
-18.8%
Net Margin
Revenue YoY
3.7%
24.3%
Net Profit YoY
EPS (diluted)
$0.93
$-0.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HTB
HTB
IMCR
IMCR
Q4 25
$53.6M
$104.5M
Q3 25
$54.1M
$103.7M
Q2 25
$54.4M
$98.0M
Q1 25
$50.9M
$93.9M
Q4 24
$51.7M
$84.1M
Q3 24
$50.6M
$80.2M
Q2 24
$50.6M
$75.4M
Q1 24
$50.0M
$70.5M
Net Profit
HTB
HTB
IMCR
IMCR
Q4 25
Q3 25
$16.5M
$-177.0K
Q2 25
$17.2M
$-10.3M
Q1 25
$14.5M
$5.0M
Q4 24
Q3 24
$13.1M
$8.7M
Q2 24
$12.4M
$-11.6M
Q1 24
$15.1M
$-24.4M
Gross Margin
HTB
HTB
IMCR
IMCR
Q4 25
97.4%
Q3 25
99.5%
Q2 25
98.9%
Q1 25
99.1%
Q4 24
99.6%
Q3 24
99.4%
Q2 24
97.7%
Q1 24
99.7%
Operating Margin
HTB
HTB
IMCR
IMCR
Q4 25
37.0%
-18.8%
Q3 25
38.5%
-6.9%
Q2 25
40.1%
-15.2%
Q1 25
36.2%
-3.9%
Q4 24
35.4%
-23.1%
Q3 24
33.2%
-10.6%
Q2 24
31.3%
-21.2%
Q1 24
38.0%
-37.6%
Net Margin
HTB
HTB
IMCR
IMCR
Q4 25
Q3 25
30.5%
-0.2%
Q2 25
31.6%
-10.5%
Q1 25
28.5%
5.4%
Q4 24
Q3 24
25.9%
10.9%
Q2 24
24.6%
-15.4%
Q1 24
30.1%
-34.7%
EPS (diluted)
HTB
HTB
IMCR
IMCR
Q4 25
$0.93
$-0.61
Q3 25
$0.95
$0.00
Q2 25
$1.00
$-0.20
Q1 25
$0.84
$0.10
Q4 24
$0.83
$-0.47
Q3 24
$0.76
$0.17
Q2 24
$0.73
$-0.23
Q1 24
$0.88
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HTB
HTB
IMCR
IMCR
Cash + ST InvestmentsLiquidity on hand
$324.7M
$864.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$600.7M
$381.0M
Total Assets
$4.5B
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HTB
HTB
IMCR
IMCR
Q4 25
$324.7M
$864.2M
Q3 25
$315.8M
$892.4M
Q2 25
$297.2M
$882.8M
Q1 25
$299.8M
$837.0M
Q4 24
$279.2M
$820.4M
Q3 24
$293.5M
$901.3M
Q2 24
$294.2M
$859.6M
Q1 24
$380.5M
$832.8M
Total Debt
HTB
HTB
IMCR
IMCR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$438.7M
Q2 24
$452.5M
Q1 24
$452.5M
Stockholders' Equity
HTB
HTB
IMCR
IMCR
Q4 25
$600.7M
$381.0M
Q3 25
$595.8M
$396.6M
Q2 25
$579.3M
$388.5M
Q1 25
$565.4M
$378.5M
Q4 24
$551.8M
$360.7M
Q3 24
$540.0M
$377.8M
Q2 24
$523.6M
$359.1M
Q1 24
$513.2M
$359.5M
Total Assets
HTB
HTB
IMCR
IMCR
Q4 25
$4.5B
$1.1B
Q3 25
$4.6B
$1.1B
Q2 25
$4.6B
$1.1B
Q1 25
$4.6B
$1.0B
Q4 24
$4.6B
$1.0B
Q3 24
$4.6B
$1.1B
Q2 24
$4.7B
$1.0B
Q1 24
$4.7B
$994.0M
Debt / Equity
HTB
HTB
IMCR
IMCR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.16×
Q2 24
1.26×
Q1 24
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HTB
HTB
IMCR
IMCR
Operating Cash FlowLast quarter
$49.5M
$-32.7M
Free Cash FlowOCF − Capex
$45.3M
$-35.5M
FCF MarginFCF / Revenue
84.5%
-34.0%
Capex IntensityCapex / Revenue
7.8%
2.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$93.8M
$-15.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HTB
HTB
IMCR
IMCR
Q4 25
$49.5M
$-32.7M
Q3 25
$-11.3M
$-4.5M
Q2 25
$-8.8M
$26.0M
Q1 25
$71.7M
$435.0K
Q4 24
$45.4M
$-14.0M
Q3 24
$43.8M
$21.1M
Q2 24
$5.9M
$23.5M
Q1 24
$-9.0M
$-4.6M
Free Cash Flow
HTB
HTB
IMCR
IMCR
Q4 25
$45.3M
$-35.5M
Q3 25
$-12.0M
$-5.2M
Q2 25
$-10.2M
$25.6M
Q1 25
$70.7M
$137.0K
Q4 24
$42.4M
$-17.5M
Q3 24
$43.1M
$20.3M
Q2 24
$5.7M
$23.1M
Q1 24
$-9.6M
$-5.0M
FCF Margin
HTB
HTB
IMCR
IMCR
Q4 25
84.5%
-34.0%
Q3 25
-22.2%
-5.0%
Q2 25
-18.7%
26.1%
Q1 25
138.7%
0.1%
Q4 24
82.0%
-20.9%
Q3 24
85.1%
25.3%
Q2 24
11.2%
30.7%
Q1 24
-19.2%
-7.1%
Capex Intensity
HTB
HTB
IMCR
IMCR
Q4 25
7.8%
2.8%
Q3 25
1.4%
0.7%
Q2 25
2.5%
0.4%
Q1 25
2.0%
0.3%
Q4 24
5.9%
4.3%
Q3 24
1.3%
1.0%
Q2 24
0.5%
0.4%
Q1 24
1.1%
0.6%
Cash Conversion
HTB
HTB
IMCR
IMCR
Q4 25
Q3 25
-0.68×
Q2 25
-0.51×
Q1 25
4.93×
0.09×
Q4 24
Q3 24
3.34×
2.42×
Q2 24
0.48×
Q1 24
-0.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons